These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6733843)

  • 1. The use of a fluorescent methotrexate probe to monitor the effects of three vinca alkaloids on a mixed population of parental L1210 and gene-amplified methotrexate-resistant cells by flow cytometry.
    Poppitt DG; McGown AT; Fox BW
    Cancer Chemother Pharmacol; 1984; 13(1):54-7. PubMed ID: 6733843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of vinca alkaloids in enhancing the sensitivity of a methotrexate-resistant (L1210/R7A) line, studied by flow cytometric and chromosome number analysis.
    McGown AT; Poppitt DG; Swindell R; Fox BW
    Cancer Chemother Pharmacol; 1984; 13(1):47-53. PubMed ID: 6733842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collateral sensitivity of a methotrexate-resistant L1210 cell line to the vinca alkaloids.
    Poppitt DG; McGown AT; Fox BW
    Cancer Chemother Pharmacol; 1984; 13(1):43-6. PubMed ID: 6733841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new fluorescent dihydrofolate reductase probe for studies of methotrexate resistance.
    Rosowsky A; Wright JE; Shapiro H; Beardsley P; Lazarus H
    J Biol Chem; 1982 Dec; 257(23):14162-7. PubMed ID: 7142200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a functional defect in the translocation of the methotrexate transport carrier in a methotrexate-resistant murine L1210 leukemia cell line.
    Schuetz JD; Matherly LH; Westin EH; Goldman ID
    J Biol Chem; 1988 Jul; 263(20):9840-7. PubMed ID: 2838483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of methotrexate polyglutamates in L1210 murine leukemia cells.
    Whitehead VM
    Cancer Res; 1977 Feb; 37(2):408-12. PubMed ID: 832265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cells.
    Chu BC; Fan CC; Howell SB
    J Natl Cancer Inst; 1981 Jan; 66(1):121-4. PubMed ID: 6935452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient inhibition of DNA synthesis by 5-fluorodeoxyuridine leads to overexpression of dihydrofolate reductase with increased frequency of methotrexate resistance.
    Schuetz JD; Gorse KM; Goldman ID; Westin EH
    J Biol Chem; 1988 Jun; 263(16):7708-12. PubMed ID: 2967290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fluorescent analogue of methotrexate as a probe for folate antagonist molecular receptors.
    Susten SS; Kempton RJ; Black AM; Freisheim JH
    Biochem Pharmacol; 1984 Jun; 33(12):1957-62. PubMed ID: 6732854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rescue effect of exogenous reduced folates on methotrexate polyglutamylation and dihydrofolate reductase activity in L1210 cells.
    Balińska M
    Acta Biochim Pol; 1988; 35(3):199-205. PubMed ID: 2469275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic heterogeneity of dihydrofolate reductase from methotrexate sensitive and resistant L1210 leukemia cells.
    Iqbal MP; Rothenberg SP; Larosa C
    Proc Soc Exp Biol Med; 1985 Oct; 180(1):98-102. PubMed ID: 2412235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescent methotrexate labeling and flow cytometric analysis of cells containing low levels of dihydrofolate reductase.
    Gaudray P; Trotter J; Wahl GM
    J Biol Chem; 1986 May; 261(14):6285-92. PubMed ID: 3700393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigations on the mechanisms of methotrexate resistance in a cisplatin-resistant L1210 murine leukemia cell subline.
    Wroblewski DH; Bhushan A; Xuan Y; Brinton BT; Tritton TR; Hacker MP
    Cancer Chemother Pharmacol; 1996; 37(4):337-42. PubMed ID: 8548879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some biochemical characteristics of L1210 cell lines resistant to 6-mercaptopurine and 6-thioguanine and with increased sensitivity to methotrexate.
    Strobel-Stevens JD; El Dareer SM; Trader MW; Hill DL
    Biochem Pharmacol; 1982 Oct; 31(19):3133-7. PubMed ID: 6890814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired drug uptake in methotrexate resistant Crithidia fasciculata without changes in dihydrofolate reductase activity or gene amplification.
    Dewes H; Ostergaard HL; Simpson L
    Mol Biochem Parasitol; 1986 May; 19(2):149-61. PubMed ID: 3724795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of dihydrofolate reductase, methotrexate transport, and growth of methotrexate-sensitive and -resistant L1210 leukemia cells in vitro by 5-substituted 2,4-diaminoquinazolines.
    Susten SS; Hynes JB; Kumar A; Freisheim JH
    Biochem Pharmacol; 1985 Jun; 34(12):2163-7. PubMed ID: 4004934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric evaluation of the cell cycle perturbations induced by S12363, a new vinca alkaloid derivative.
    Leonce S; Anstett M; Combe-Perez V; Pierre A
    Anticancer Drugs; 1990 Dec; 1(2):179-83. PubMed ID: 2131051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate-resistant L1210 clonal cell lines derived in vivo.
    Sirotnak FM; Moccio DM; Kelleher LE; Goutas LJ
    Cancer Res; 1981 Nov; 41(11 Pt 1):4447-52. PubMed ID: 7306968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate analogues. 23. Synthesis, dihydrofolate reductase affinity, cytotoxicity, and in vivo antitumor activity of some putative degradation products of methotrexate-poly(L-lysine) conjugates.
    Rosowsky A; Forsch RA; Freisheim JH; Galivan J; Wick M
    J Med Chem; 1984 Jul; 27(7):888-93. PubMed ID: 6737432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical correlates of responsiveness and collateral sensitivity of some methotrexate-resistant murine tumors to the lipophilic antifolate, metoprine.
    Sirotnak FM; Moccio DM; Goutas LJ; Kelleher LE; Montgomery JA
    Cancer Res; 1982 Mar; 42(3):924-8. PubMed ID: 7059991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.